propranolol has been researched along with Uremia in 52 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
Excerpt | Relevance | Reference |
---|---|---|
"Propranolol is widely employed in hemodialysis patients for the control of renin-dependent hypertension." | 7.66 | Propranolol-associated hypoglycemia in patients on maintenance hemodialysis. ( Gelfand, M; Knepshield, J; Novello, A; Preuss, HG; Zarate, A, 1981) |
" The common factor in all 5 patients was propranolol administration for the treatment of hypertension." | 7.66 | Hypoglycemia in chronic hemodialysis patients: association with propranolol use. ( Albin, J; Grajower, MM; Walter, L, 1980) |
"The hemodynamic mechanism of the hypotensive effect of propranolol was studied by quantitative radiocardiography in 8 patients with dialysis-resistant hypertension." | 7.66 | Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension. ( Contini, C; Maggiore, Q; Monzani, G; Zoccali, C, 1978) |
"Propranolol was the only antihypertensive drug common to all 16 patients." | 5.26 | Spurious hyperbilirubinemia in uremic patients on propranolol therapy. ( McKinney, TD; Stone, WJ; Warnock, LG, 1979) |
"Propranolol is widely employed in hemodialysis patients for the control of renin-dependent hypertension." | 3.66 | Propranolol-associated hypoglycemia in patients on maintenance hemodialysis. ( Gelfand, M; Knepshield, J; Novello, A; Preuss, HG; Zarate, A, 1981) |
" The common factor in all 5 patients was propranolol administration for the treatment of hypertension." | 3.66 | Hypoglycemia in chronic hemodialysis patients: association with propranolol use. ( Albin, J; Grajower, MM; Walter, L, 1980) |
"The hemodynamic mechanism of the hypotensive effect of propranolol was studied by quantitative radiocardiography in 8 patients with dialysis-resistant hypertension." | 3.66 | Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension. ( Contini, C; Maggiore, Q; Monzani, G; Zoccali, C, 1978) |
" In contrast, acute uremia did elicit a change in the bioavailability of orally administered S(-)-propranolol." | 1.27 | Altered S(--)-propranolol disposition in bilateral ureter-ligated rats. ( Laganière, S; Shen, DD, 1987) |
" Steady-state daily dosage of propranolol averaged 225 +/- 36 mg (range, 80 to 400)." | 1.26 | Massive propranolol metabolite retention during maintenance hemodialysis. ( Stone, WJ; Walle, T, 1980) |
"Propranolol was the only antihypertensive drug common to all 16 patients." | 1.26 | Spurious hyperbilirubinemia in uremic patients on propranolol therapy. ( McKinney, TD; Stone, WJ; Warnock, LG, 1979) |
" A significant increase in the fraction of the dose available to the systemic circulation was also found, together with a modification of apparent plasma half-life and volume of distribution in regular dialysis patients during the dialysis day as compared with the after-dialysis day." | 1.26 | Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. ( Bianchetti, G; Brancaccio, D; Gomeni, R; Graziani, G; Leonetti, G; Manfrin, M; Morganti, A; Morselli, PL; Ponticelli, C; Sega, R, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (98.08) | 18.7374 |
1990's | 1 (1.92) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianchetti, G | 2 |
Brancaccio, D | 4 |
Forette, F | 1 |
Henry, JF | 1 |
Hervy, MP | 1 |
Ganansia, J | 1 |
Gomeni, R | 2 |
Kilborn, JR | 1 |
Morselli, PL | 2 |
Coevoet, B | 6 |
Lambrey, G | 1 |
de Frémont, JF | 3 |
Hardin, JM | 1 |
Desplan, C | 4 |
Calmette, C | 4 |
Makdassi, R | 5 |
Andrejak, M | 4 |
Moukhtar, MS | 4 |
Fournier, A | 6 |
Riegel, W | 1 |
Stepinski, J | 1 |
Hörl, WH | 1 |
Heidland, A | 1 |
Morinière, P | 2 |
Sebert, JL | 3 |
Decourt, S | 2 |
Guéris, J | 2 |
Fichtl, B | 1 |
Gerdsmeier, W | 1 |
Feinroth, MV | 1 |
Goldstein, EJ | 1 |
Josephson, A | 1 |
Friedman, EA | 1 |
Zarate, A | 1 |
Gelfand, M | 1 |
Novello, A | 1 |
Knepshield, J | 1 |
Preuss, HG | 1 |
Decourcelle, PH | 1 |
Kassouf, J | 1 |
Roussel, A | 1 |
Gheerbrand, JD | 1 |
Schneck, DW | 1 |
Pritchard, JF | 1 |
Gibson, TP | 2 |
Vary, JE | 1 |
Hayes, AH | 1 |
Grim, CE | 1 |
Gheerbrant, JD | 1 |
Tolani, M | 2 |
Stone, WJ | 2 |
Walle, T | 1 |
Grajower, MM | 1 |
Walter, L | 1 |
Albin, J | 1 |
Iaina, A | 1 |
Solomon, S | 1 |
Eliahou, H | 1 |
Harken, AH | 1 |
Roux, A | 1 |
Baglin, A | 1 |
Domart, M | 1 |
Aubert, P | 1 |
Flouvat, B | 1 |
Fritel, D | 1 |
Gherbrand, JD | 1 |
Caillens, G | 1 |
Galmozzi, C | 2 |
Casati, S | 2 |
Ponticelli, C | 3 |
Eastwood, JB | 1 |
Mogensen, CE | 1 |
Lhoste, F | 2 |
Drüeke, T | 1 |
Larno, S | 1 |
Man, NK | 1 |
Zingraff, J | 1 |
Jlngers, P | 1 |
Boissier, JR | 1 |
Cecchettin, M | 1 |
Albertini, A | 1 |
Luisetto, G | 1 |
Heynen, G | 1 |
Franchimont, P | 1 |
Nivatpumin, T | 2 |
Yipintsoi, T | 2 |
Penpargkul, S | 1 |
Scheuer, J | 2 |
Wauters, JP | 1 |
Schaller, MD | 1 |
Brunner, HR | 1 |
McKinney, TD | 1 |
Warnock, LG | 1 |
Kimata, S | 1 |
Takahashi, S | 1 |
Noda, H | 1 |
Nakao, H | 1 |
Hirosawa, K | 1 |
Rurale, D | 1 |
Belloli, S | 1 |
Aroldi, A | 1 |
Graziani, G | 2 |
Maggiore, Q | 2 |
Zoccali, C | 2 |
Monzani, G | 1 |
Contini, C | 1 |
Kikawada, R | 2 |
Noro, C | 2 |
Morganti, A | 1 |
Leonetti, G | 1 |
Manfrin, M | 1 |
Sega, R | 1 |
Pessina, AC | 1 |
Palatini, P | 1 |
Pigato, R | 1 |
Hlede, M | 1 |
Tsuyusaki, T | 1 |
Muramatsu, J | 1 |
Kakubari, Y | 1 |
Briggs, WA | 1 |
Lowenthal, DT | 1 |
Cirksena, WJ | 1 |
Price, WE | 1 |
Flamenbaum, W | 1 |
Biagini, M | 1 |
Misefari, M | 1 |
Castellino, P | 1 |
Bia, MJ | 1 |
DeFronzo, RA | 1 |
Bree, F | 1 |
Souchet, T | 1 |
Baatard, R | 1 |
Fontenaille, C | 1 |
Tillement, JP | 1 |
Zawada, ET | 1 |
Baylor, P | 1 |
Shilo, S | 1 |
Zonszein, J | 1 |
Shamoon, H | 1 |
Laganière, S | 1 |
Shen, DD | 2 |
Tiula, E | 1 |
Neuvonen, PJ | 1 |
Terao, N | 1 |
Watt, DA | 1 |
Smith, EC | 1 |
Dhar, SK | 1 |
Freedman, P | 1 |
Onesti, G | 1 |
Skrabal, F | 1 |
Acchiardo, SR | 1 |
Black, WD | 1 |
Britt, L | 1 |
McKeown, JW | 1 |
Johnson, JG | 1 |
Hatch, F | 1 |
Seedat, YK | 1 |
Naidoo, DN | 1 |
Swenson, RS | 2 |
Peterson, DT | 1 |
Eshleman, M | 1 |
Reaven, GM | 2 |
Weisinger, J | 1 |
Greene, W | 1 |
Taylor, JB | 1 |
Jameson, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease[NCT01087749] | Phase 1 | 24 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for propranolol and Uremia
Article | Year |
---|---|
The surgical significance of the oxyhemoglobin dissociation curve.
Topics: Anemia; Angina Pectoris; Animals; Blood; Diabetes Mellitus; Diphosphoglyceric Acids; Erythrocytes; H | 1977 |
3 trials available for propranolol and Uremia
Article | Year |
---|---|
Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Betaxolol; Female; Humans; Male; Propanolamines; Pr | 1980 |
Adrenergic modulation of potassium metabolism in uremia.
Topics: Adult; Blood Pressure; Heart Rate; Humans; Metoprolol; Potassium; Propranolol; Uremia | 1990 |
Renal hemodynamic changes after beta-blocker-diuretic combination therapy in azotemic hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Glomerular Filtration Rate; Hum | 1986 |
48 other studies available for propranolol and Uremia
Article | Year |
---|---|
[Evidence, in uremic man, of the role of beta 2 adrenergic receptors in the secretion of parathyroid hormone and calcitonin (author's transl)].
Topics: Adult; Calcitonin; Female; Heart Rate; Humans; Kidney Diseases; Male; Metoprolol; Parathyroid Hormon | 1980 |
Effect of hormones on hepatocyte gluconeogenesis in different models of acute uraemia.
Topics: Acute Kidney Injury; Animals; Blood Glucose; Bucladesine; Dihydroxyacetone; Disease Models, Animal; | 1982 |
Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremia.
Topics: Adult; Aged; Atenolol; Bicarbonates; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Ag | 1982 |
Increased plasma protein binding of propranolol in rabbits with acute renal failure.
Topics: Acute Kidney Injury; Animals; Blood Proteins; Creatinine; Female; Glycerol; Male; Phenytoin; Propran | 1981 |
Infection complicating intrapericardial steroid instillation in uremic pericarditis.
Topics: Adult; Drainage; Humans; Male; Minoxidil; Pericarditis; Propranolol; Staphylococcal Infections; Urem | 1981 |
Propranolol-associated hypoglycemia in patients on maintenance hemodialysis.
Topics: Adult; Humans; Hypertension; Hypoglycemia; Male; Propranolol; Renal Dialysis; Uremia | 1981 |
Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
Topics: Adult; Aged; Atenolol; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism, Secondary; Male; | 1981 |
Effect of dose and uremia on plasma and urine profiles of propranolol metabolites.
Topics: Absorption; Adult; Biotransformation; Half-Life; Humans; Kinetics; Liver; Male; Metabolic Clearance | 1980 |
Management of malignant hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Diuretics; Drug | 1980 |
Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients.
Topics: Adult; Calcitonin; Female; Heart Rate; Humans; Male; Metoprolol; Parathyroid Hormone; Propanolamines | 1980 |
Massive propranolol metabolite retention during maintenance hemodialysis.
Topics: Adult; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Propranolol; Renal Dialysis; Ure | 1980 |
Hypoglycemia in chronic hemodialysis patients: association with propranolol use.
Topics: Adult; Aged; Female; Humans; Hypertension; Hypoglycemia; Male; Propranolol; Renal Dialysis; Uremia | 1980 |
beta-Adrenergic blockade reduces the severity of acute renal failure in rats.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Angiotensin II; Animals; Creatinine; Disease Model | 1976 |
[Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Dose-Response Relationship, Drug; Humans; H | 1977 |
Acute effects of propranolol and metoprolol on plasma concentrations of parathyroid hormone and calcitonin in uraemic patients.
Topics: Adult; Bicarbonates; Blood Proteins; Calcitonin; Calcium; Female; Heart Rate; Humans; Hydrogen-Ion C | 1979 |
Propranolol therapy for secondary hyperparathyroidism in uraemia.
Topics: Calcitonin; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Metoprolol; Parathyro | 1978 |
Propranolol in uraemic osteodystrophy.
Topics: Alkaline Phosphatase; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Parathyroid Hormone; | 1978 |
Propranolol in uraemic osteodystrophy.
Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Propranolo | 1979 |
Diabetes and hypertension.
Topics: Blood Pressure; Diabetes Mellitus; Diabetic Nephropathies; Furosemide; Glomerular Filtration Rate; H | 1979 |
Anti-beta adrenoreceptor blockade activity of plasma ultrafiltrate in two uraemic patients: effect of parathyroidectomy.
Topics: Animals; Guinea Pigs; Heart; Heart Atria; Heart Rate; Humans; Hyperparathyroidism; In Vitro Techniqu | 1976 |
[Calcitonin, gastrin, parathyroid hormone and the autonomic nervous system].
Topics: Calcitonin; Gastrins; Humans; Parathyroid Hormone; Propranolol; Receptors, Adrenergic; Receptors, Ad | 1978 |
Increased cardiac contractility in acute uremia: interrelationships with hypertension.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Chlorides; Heart Rate; Hydrogen-Ion Concentration; Hyp | 1975 |
[Discontinuation of chronic hemodialysis due to improved kidney function caused by the control of arterial hypertension].
Topics: Adult; Creatinine; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Propr | 1979 |
Spurious hyperbilirubinemia in uremic patients on propranolol therapy.
Topics: Bilirubin; Dose-Response Relationship, Drug; Humans; Hyperbilirubinemia; Propranolol; Renal Dialysis | 1979 |
[HIgh output heart failure (author's transl)].
Topics: Adult; Anemia; Animals; Arteriovenous Fistula; Cardiac Output; Dogs; Female; Hemodynamics; Humans; H | 1979 |
Propranolol and uraemic osteodystrophy.
Topics: Alkaline Phosphatase; Calcitonin; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hydroxyp | 1979 |
Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Electrocardiography; Female; Hemodynamics; Humans; Hypertensi | 1978 |
Clinical evaluation of myocardial contractility and its problems.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Heart Rate; Humans; Hypertension; Isoproterenol; Myoc | 1977 |
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment.
Topics: Adult; Female; Humans; Kinetics; Male; Middle Aged; Propranolol; Renal Dialysis; Renin; Time Factors | 1976 |
[Changes in kidney function during hypotensive treatment].
Topics: Adult; Aged; Clonidine; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazid | 1976 |
Evaluation of myocardial contractility by the non-invasive method.
Topics: Aged; Atrial Fibrillation; Blood Pressure; Cardiac Output; Depression, Chemical; Digitalis Glycoside | 1975 |
Propranolol in hypertensive dialysis patients: efficacy and compliance.
Topics: Adolescent; Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Patient Co | 1975 |
Propranolol treatment of resistant arterial hypertension in patients on chronic dialysis.
Topics: Body Weight; Heart Rate; Humans; Hypertension, Renal; Propranolol; Renal Dialysis; Renin; Uremia | 1975 |
Effects of moderate uremia on cardiac contractile responses.
Topics: Animals; Blood Pressure; Calcium; Creatinine; Heart; Male; Myocardial Contraction; Organ Size; Phosp | 1975 |
Inhibition of (-) [125I]-iodocyanopindolol binding to rat lung beta adrenoceptors by uremic plasma ultrafiltrates.
Topics: Animals; Humans; In Vitro Techniques; Iodine Radioisotopes; Iodocyanopindolol; Kinetics; Lung; Male; | 1987 |
Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
Topics: Adult; Blood Glucose; Female; Glucagon; Humans; Insulin; Insulin Secretion; Kinetics; Male; Middle A | 1986 |
Altered S(--)-propranolol disposition in bilateral ureter-ligated rats.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Blood Proteins; Injections, Intravenous; Intesti | 1987 |
Effect of total drug concentration on the free fraction in uremic sera.
Topics: Adult; Aged; Creatinine; Diazepam; Female; Humans; Male; Middle Aged; Orosomucoid; Pharmaceutical Pr | 1986 |
Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
Topics: Acute Kidney Injury; Animals; Blood Glucose; Blood Proteins; Kinetics; Liver; Male; Metabolic Cleara | 1985 |
Sensitivity to propranolol after digoxin intoxication.
Topics: Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Cardiac Complexes, Premature | 1968 |
Propranolol in the management of hypertension in a long-term dialysis program.
Topics: Administration, Oral; Humans; Hypertension, Renal; Long-Term Care; Propranolol; Renal Dialysis; Urem | 1974 |
Dialysis and volume control.
Topics: Humans; Hydralazine; Hypertension; Minoxidil; Nephrectomy; Propranolol; Renal Dialysis; Sodium; Ultr | 1974 |
Half-life of plasma renin activity in normal subjects and in malignant hypertension.
Topics: Adolescent; Adult; Chronic Disease; Female; Half-Life; Humans; Hypertension, Malignant; Male; Nephre | 1974 |
Experience with hemodialysis and renal transplantation in patients with malignant hypertension.
Topics: Acute Kidney Injury; Adult; Brain Diseases; Diazoxide; Diet Therapy; Female; Follow-Up Studies; Furo | 1974 |
Evaluation of amiloride combined with hydrochlorothiazide (Moduretic) in the treatment of hypertension.
Topics: Adult; Aged; Amiloride; Benzothiadiazines; Diuretics; Drug Combinations; Female; Guanethidine; Human | 1973 |
Effect of acute uremia on various aspects of carbohydrate metabolism in dogs.
Topics: Acute Disease; Animals; Blood Glucose; Carbohydrate Metabolism; Creatinine; Dogs; Epinephrine; Fasti | 1973 |
Comparison of the effects of metabolic acidosis and acute uremia on carbohydrate tolerance.
Topics: Acidosis; Acute Disease; Ammonium Chloride; Animals; Blood Glucose; Dogs; Epinephrine; Female; Gluco | 1972 |
[Effects of Inderal in the treatment of uremic hypertension].
Topics: Adult; Allopurinol; Diabetic Coma; Drug Combinations; Drug Interactions; Female; Humans; Hydralazine | 1971 |